SCHEMBL13345733

SCHEMBL13345733

C[C@@H](NCC[C@]1(c2ccc(Cl)cc2)CCCNC1)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 19/20 0.43
SLC6A3 Q01959 16/20 0.43
SLC6A2 P23975 9/20 0.43
CYP2D6 P10635 1/20 0.40
TACR1 P25103 3/20 0.35
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
HTR2A P28223 1/20 0.33
OPRK1 P41145 1/20 0.33
HTR2B P41595 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13345732 1.00 SLC6A4 (0.43) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL13345725 0.88 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL13345106 0.88 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL3469294 0.88 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2CYP2D6
SCHEMBL13345108 0.88 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2CYP2D6
SCHEMBL3469299 0.88 SLC6A4 (0.60) SLC6A4SLC6A3SLC6A2CYP2D6
SCHEMBL13345727 0.86 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL13345738 0.86 SLC6A4 (0.49) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL1985613 0.81 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2CYP2D6TACR1
SCHEMBL1985616 0.81 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2CYP2D6TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010071575-A1 QUATERNARY PIPERIDINE DERIVATIVES AND USES THEREOF ASTRAZENECA AB (SE) 2010-06-24 WO disclosed